{"text": ["4", "Reasons", "Why", "Glaxo", "(GSK)", "Stock", "Can", "be", "a", "Great", "Pick", "in", "'18"], "created_at": "2018-03-22 18:08:58"}
{"text": ["4", "Reasons", "Why", "Glaxo", "(GSK)", "Stock", "Can", "be", "a", "Great", "Pick", "in", "'18"], "created_at": "2018-03-22 18:08:58"}
{"text": ["30", "Most", "Obese", "Countries", "In", "The", "World", "in", "2018:", "Biggest", "Anti-Obesity", "Drug", "Markets"], "created_at": "2018-03-22 16:47:39"}
{"text": ["Roche's", "(RHHBY)", "Lucentis", "0.3", "mg", "PFS", "Receives", "FDA", "Approval"], "created_at": "2018-03-22 16:13:54"}
{"text": ["Roche's", "(RHHBY)", "Lucentis", "0.3", "mg", "PFS", "Receives", "FDA", "Approval"], "created_at": "2018-03-22 16:13:54"}
{"text": ["Biotech", "Winners", "And", "Losers", "From", "Congress'", "Latest", "Funding", "Bill"], "created_at": "2018-03-22 15:46:06"}
{"text": ["4", "Reasons", "Why", "Glaxo", "(GSK)", "Stock", "Can", "be", "a", "Great", "Pick", "in", "&apos;18"], "created_at": "2018-03-22 15:31:03"}
{"text": ["US", "Generics", "Market", "Consolidation", "Continues", "to", "Affect", "Teva"], "created_at": "2018-03-22 14:31:33"}
{"text": ["Roche&apos;s", "(RHHBY)", "Lucentis", "0.3", "mg", "PFS", "Receives", "FDA", "Approval"], "created_at": "2018-03-22 14:05:02"}
{"text": ["The", "Swiss", "Stock", "Market", "Fell", "On", "Trade", "War", "Anxiety"], "created_at": "2018-03-22 13:17:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Fell", "On", "Trade", "War", "Anxiety"], "created_at": "2018-03-22 13:17:00"}
{"text": ["Exploring", "the", "Financial", "Performance", "of", "Akcea", "Therapeutics"], "created_at": "2018-03-22 11:31:43"}
{"text": ["FENC", "On", "Fast", "Track,", "SPHS", "To", "Report", "Data", "In", "Q2,", "REGN,", "ALNY", "Team", "Up", "For", "NASH"], "created_at": "2018-03-22 02:35:00"}
{"text": ["FENC", "On", "Fast", "Track,", "SPHS", "To", "Report", "Data", "In", "Q2,", "REGN,", "ALNY", "Team", "Up", "For", "NASH"], "created_at": "2018-03-22 02:35:00"}
